Date published: 2026-4-1

1-800-457-3801

SCBT Portrait Logo
Seach Input

CLCA4_Clac4 Inhibitors

CLCA4_Clac4 Inhibitors represent a specialized class of chemical compounds designed to selectively hinder the activity of the CLCA4 (Chloride Channel Accessory 4) or Clac4 protein. CLCA4 belongs to the calcium-activated chloride channel regulators, a group of proteins implicated in the modulation of chloride transport across cell membranes. The development of inhibitors targeting CLCA4_Clac4 is integral to scientific inquiry, serving as specific tools for unraveling the molecular functions and regulatory roles associated with this particular protein. As part of the chloride channel regulatory family, CLCA4_Clac4 likely plays a role in modulating ion flux across cellular membranes, influencing cellular excitability and secretory functions.

The synthesis and refinement of CLCA4_Clac4 inhibitors require a thorough understanding of the protein's structural characteristics and its interactions within cellular contexts. These inhibitors are meticulously crafted for specificity, designed to selectively bind to key regions of CLCA4_Clac4 and interfere with its normal regulatory functions. By employing these inhibitory compounds in experimental settings, researchers can investigate the consequences of CLCA4_Clac4 inhibition on cellular ion homeostasis, shedding light on the protein's potential contributions to cellular physiology. The study of CLCA4_Clac4 inhibitors contributes to the broader exploration of ion channel regulation, providing insights into the intricate molecular mechanisms that govern cellular responses to changes in chloride concentrations and supporting a deeper comprehension of the diverse functions associated with this particular class of proteins.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Fluorouracil

51-21-8sc-29060
sc-29060A
1 g
5 g
$37.00
$152.00
11
(1)

5-Fluorouracil interferes with RNA synthesis, affecting the expression of chloride channel accessory 4 (CLCA4).

Actinomycin D

50-76-0sc-200906
sc-200906A
sc-200906B
sc-200906C
sc-200906D
5 mg
25 mg
100 mg
1 g
10 g
$74.00
$243.00
$731.00
$2572.00
$21848.00
53
(3)

Actinomycin D binds to DNA, inhibiting transcription and reducing the synthesis of CLCA4.

Cycloheximide

66-81-9sc-3508B
sc-3508
sc-3508A
100 mg
1 g
5 g
$41.00
$84.00
$275.00
127
(6)

Cycloheximide inhibits protein synthesis, leading to a decrease in CLCA4 levels.

Puromycin dihydrochloride

58-58-2sc-108071
sc-108071B
sc-108071C
sc-108071A
25 mg
250 mg
1 g
50 mg
$42.00
$214.00
$832.00
$66.00
394
(16)

Puromycin induces premature termination of protein synthesis, contributing to the downregulation of CLCA4 expression.

Rifampicin

13292-46-1sc-200910
sc-200910A
sc-200910B
sc-200910C
1 g
5 g
100 g
250 g
$97.00
$328.00
$676.00
$1467.00
6
(1)

Rifampicin inhibits bacterial RNA polymerase, indirectly suppressing CLCA4 expression by affecting transcription processes.

Anisomycin

22862-76-6sc-3524
sc-3524A
5 mg
50 mg
$99.00
$259.00
36
(2)

Anisomycin blocks peptidyl transferase activity, inhibiting protein synthesis and reducing the levels of CLCA4.

Cordycepin

73-03-0sc-203902
10 mg
$101.00
5
(1)

Cordycepin interferes with mRNA synthesis, impacting transcription and subsequently decreasing the expression of CLCA4.

Mycophenolic acid

24280-93-1sc-200110
sc-200110A
100 mg
500 mg
$69.00
$266.00
8
(1)

Mycophenolic acid inhibits inosine monophosphate dehydrogenase, indirectly affecting CLCA4 expression by disrupting purine synthesis.

Blasticidin S Hydrochloride

3513-03-9sc-204655A
sc-204655
25 mg
100 mg
$367.00
$520.00
20
(2)

Blasticidin S induces premature termination during translation, inhibiting protein synthesis and reducing the synthesis of CLCA4.